share_log

Palisade Bio Q4 EPS $(0.25) Beats $(0.34) Estimate

Palisade Bio Q4 EPS $(0.25) Beats $(0.34) Estimate

Palisade Bio第四季度每股收益美元(0.25美元)超過預期(0.34美元)
Benzinga ·  03/27 08:04

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.34) by 26.47 percent. This is a 98.45 percent increase over losses of $(16.16) per share from the same period last year.

Palisade Bio(納斯達克股票代碼:PALI)公佈的季度虧損爲每股0.25美元,比分析師普遍預期的0.34美元(0.34美元)高出26.47%。這比去年同期每股虧損16.16美元(16.16美元)增長了98.45%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論